During the past decade, Royal Women's Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Women's Hospital" #1 sponsor was "Queensland Centre for Gynaecological Cancer" with 3 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "MEI Pharma, Inc." with 1 trials sponsored, "Medical Research Council" with 1 trials sponsored and "NCIC Clinical Trials Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Women's Hospital" #1 collaborator was "Cancer Australia" with 2 trials as a collaborator, "Queensland University of Technology" with 2 trials as a collaborator, "The University of Queensland" with 2 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator and "Cancer Council New South Wales" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Royal Women's Hospital" are "Ovarian Cancer" (5 trials), "Fallopian Tube Cancer" (4 trials), "Primary Peritoneal Cavity Cancer" (4 trials), "Endometrial Cancer" (3 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Royal Women's Hospital" in a lesser frequency.

Most popular intervention types in "Royal Women's Hospital" are "Drug" (5 trials), "Procedure" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (2 trials), "paclitaxel" (2 trials), "Levonorgestrel" (1 trials), "Metformin" (1 trials) and "Total Abdominal Hysterectomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Women's Hospital" are 8 trials for "Female" genders.

Currently, there are NaN active trials in "Royal Women's Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Royal Women's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Women's Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".